These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11136646)

  • 41. Sodium valproate and thrombocytopenia.
    Winfield DA; Benton P; Espir ML; Arthur LJ
    Br Med J; 1976 Oct; 2(6042):981. PubMed ID: 788857
    [No Abstract]   [Full Text] [Related]  

  • 42. Sodium valproate and platelet counts.
    Eastham RD; Jancar J
    Br Med J; 1980 Jan; 280(6208):186. PubMed ID: 6766772
    [No Abstract]   [Full Text] [Related]  

  • 43. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical features and functional impact of valproate-induced tremor.
    Alonso-Juarez M; Torres-Russotto D; Crespo-Morfin P; Baizabal-Carvallo JF
    Parkinsonism Relat Disord; 2017 Nov; 44():147-150. PubMed ID: 28941829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet count and function in children receiving sodium valproate.
    Verrotti A; Greco R; Matera V; Altobelli E; Morgese G; Chiarelli F
    Pediatr Neurol; 1999 Sep; 21(3):611-4. PubMed ID: 10513686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Valproate prescriptions for nonepilepsy disorders in reproductive-age women.
    Adedinsewo DA; Thurman DJ; Luo YH; Williamson RS; Odewole OA; Oakley GP
    Birth Defects Res A Clin Mol Teratol; 2013 Jun; 97(6):403-8. PubMed ID: 23733498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of pancytopenia.
    Keown P; McAllister-Williams H; Young A
    J Psychopharmacol; 2006 Sep; 20(5):690-2. PubMed ID: 16714327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Valproate use in neuropsychiatric disorders in the elderly.
    Tariot PN
    Psychopharmacol Bull; 2003; 37 Suppl 2():116-28. PubMed ID: 15021866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid hormone levels in children receiving carbamazepine or valproate.
    Aggarwal A; Rastogi N; Mittal H; Chillar N; Patil R
    Pediatr Neurol; 2011 Sep; 45(3):159-62. PubMed ID: 21824562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematologic manifestations of long-term valproate therapy.
    May RB; Sunder TR
    Epilepsia; 1993; 34(6):1098-101. PubMed ID: 8243362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Valproate in psychiatric disorders: literature review and clinical guidelines.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychiatry; 1989 Mar; 50 Suppl():23-9. PubMed ID: 2494155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

  • 55. Sodium valproate and platelet-count.
    Raworth RE; Birchall G
    Lancet; 1978 Mar; 1(8065):670-1. PubMed ID: 76214
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of valproic acid on blood loss in patients with cerebral palsy.
    Chambers HG; Weinstein CH; Mubarak SJ; Wenger DR; Silva PD
    J Pediatr Orthop; 1999; 19(6):792-5. PubMed ID: 10573351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium valproate and bone marrow suppression.
    Smith FR; Boots M
    Ann Neurol; 1980 Aug; 8(2):197-9. PubMed ID: 6775583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G; Marková J; Mastík J
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
    Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.